[1]
“QSAR, human hepatocellular carcinoma anticancer screening, docking studies and in silico prediction of some N-(substituted)-9-alkyl-1- substituted-9H-β-carboline-3-carboxamide derivatives”, Int. J. Multidiscip. Curr. Res., vol. 14, no. 2, pp. 180–192, Mar. 2026, doi: 10.14741/ijmcr/v.14.2.11.